Hervé Hoppenot

Hervé Hoppenot

Chair of the BoardatIncyte· In proxies 2021–2025

Pay in FY2025-63% from the year before · Incyte stock +43.0% the same year

Hervé Hoppenot was paid $6.4M in FY2025 (Dec), down 63%. Incyte stock rose 43.0% that year.

Pay$100 in the stock at the end of FY20 → $114
Pay is from the Summary Compensation Table of each Incyte proxy. The stock line is the value of $100 put in the stock at the start, from the price change of each fiscal year. Dividends are not in it.

Experience

  1. Maze TherapeuticsPublic company · 1 yr
    • Chair of the Board2025 – Present · 1 yrNo stock prices for these years
  2. IncytePublic company · 5 yr
    • President and Chief Executive Officer2021 – Present · 5 yrStock in role +34%
  3. Bicycle Therapeutics PLCPublic company · 1 yr
    • Director2025 – Present · 1 yrNo stock prices for these years

Roles come from the proxy statements of each company.

Activity

For the press:Download CSVDownload PNGHow to use our data

Two people shown as one, or a wrong number?